Avaliação do efeito antifibrótico da Relaxina: estudo in vivo e in vitro

Detalhes bibliográficos
Autor(a) principal: Figueiredo, Camila Médici de [UNIFESP]
Data de Publicação: 2016
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Repositório Institucional da UNIFESP
dARK ID: ark:/48912/0013000004ttm
Texto Completo: https://sucupira.capes.gov.br/sucupira/public/consultas/coleta/trabalhoConclusao/viewTrabalhoConclusao.jsf?popup=true&id_trabalho=3775720
https://repositorio.unifesp.br/handle/11600/47695
Resumo: Mesangial cells (MC) and its extracellular matrix are relevant to the maintenance of glomerular filtration rate by modulating the surface available for filtration. Under stimuli such as high glucose, MC proliferate and become hypersecretory of matrix proteins and pro-fibrotic factors such as TGFβ1, contributing to glomerular sclerosis. A number of the strategies have been tested in order to reduce the fibrogenic process dependent of TGFβ1 and in this context, the pregnancy related hormone Relaxin (RLX) has been explored due to its antifibrotic capacity. Usually related to pregnancy, RLX was capable to reduce TGFβ1-induced fibrosis, and increase the secretion of metalloproteinases, which degrade matrix proteins. Thus, the objective of this study was to evaluate if high levels of endogenous RLX found during pregnancy would be able to reduce the fibrogenic process induced by unilateral ureteral obstruction (UUO). Pregnant rats, which have high levels of RLX were used. Seven days pregnant rats were submitted to UUO for 7 or 15 days. In addition to the in vivo fibrosis model, we also evaluated an in vitro model using primary mesangial cells cultured from virgin and pregnant rats. MC were cultured from kidney of pregnant and virgin rats, and stimulated with high glucose concentration (30 mM) and/or RLX (100ng/ml) for 48 hours. The Pregnant group showed to be more protected against the effects of UUO with less reduction in creatinine clearance and less interstitial collagen accumulation. In the in vitro model, high glucose stimulated the expression of RLX receptor (Rxfp1), Collagen and TGFβ1 in the Virgin group but had no effect in MC from pregnant rats. Treatment with RLX prevented these changes in Virgin group. Our results suggest that elevated levels of endogenous or exogenous RLX may have a protective role in fibrogenic process.
id UFSP_5480cf7a79610c2e1f7e82318d0ad65b
oai_identifier_str oai:repositorio.unifesp.br/:11600/47695
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Avaliação do efeito antifibrótico da Relaxina: estudo in vivo e in vitroEvaluation of antifibrotic effect of Relaxin: In vivo and in vitro studyRelaxinPregnancyRenal fibrosisPrimary mesangial cellUnilateral obstruction of the ureterRelaxinaGravidezFibrose renalCélula mesangial primáriaObstrução unilateral do ureterMesangial cells (MC) and its extracellular matrix are relevant to the maintenance of glomerular filtration rate by modulating the surface available for filtration. Under stimuli such as high glucose, MC proliferate and become hypersecretory of matrix proteins and pro-fibrotic factors such as TGFβ1, contributing to glomerular sclerosis. A number of the strategies have been tested in order to reduce the fibrogenic process dependent of TGFβ1 and in this context, the pregnancy related hormone Relaxin (RLX) has been explored due to its antifibrotic capacity. Usually related to pregnancy, RLX was capable to reduce TGFβ1-induced fibrosis, and increase the secretion of metalloproteinases, which degrade matrix proteins. Thus, the objective of this study was to evaluate if high levels of endogenous RLX found during pregnancy would be able to reduce the fibrogenic process induced by unilateral ureteral obstruction (UUO). Pregnant rats, which have high levels of RLX were used. Seven days pregnant rats were submitted to UUO for 7 or 15 days. In addition to the in vivo fibrosis model, we also evaluated an in vitro model using primary mesangial cells cultured from virgin and pregnant rats. MC were cultured from kidney of pregnant and virgin rats, and stimulated with high glucose concentration (30 mM) and/or RLX (100ng/ml) for 48 hours. The Pregnant group showed to be more protected against the effects of UUO with less reduction in creatinine clearance and less interstitial collagen accumulation. In the in vitro model, high glucose stimulated the expression of RLX receptor (Rxfp1), Collagen and TGFβ1 in the Virgin group but had no effect in MC from pregnant rats. Treatment with RLX prevented these changes in Virgin group. Our results suggest that elevated levels of endogenous or exogenous RLX may have a protective role in fibrogenic process.Células mesangiais (CM) e sua matriz extracelular possuem papel relevante na manutenção do ritmo de filtração glomerular, pois influenciam a superfície disponível para filtração glomerular. Na vigência de estímulos como o meio rico em glicose, as CMs proliferam e se tornam hipersecretoras de matriz e de fatores pró-fibróticos como o TGFβ1,contribuindo para a esclerose glomerular. Assim, diversas estratégias têm sido avaliadas com o intuito de reduzir o processo fibrogênico dependente do TGFβ1 e nesse contexto, a Relaxina (RLX) tem sido explorada devido à sua capacidade antifibrótica. Normalmente relacionada à gravidez, a RLX mostrou-se capaz de inibir a ação do TGFβ1, além de aumentar a secreção das metaloproteinases, proteínas degradadoras de matriz. Desta forma, o objetivo deste trabalho foi avaliar se a RLX seria capaz de reduzir o processo fibrogênico induzido por obstrução unilateral do ureter (OUU). Utilizamos para isso ratas prenhes, que possuem elevados níveis endógenos de RLX. Ratas virgens e prenhes de 7 dias foram submetidas à OUU por 7 ou 15 dias. Além do modelo de fibrose in vivo, também avaliamos um modelo in vitro utilizando células mesangiais primárias cultivadas a partir de rins de ratas prenhes (12 dias) e virgens, que foram estimuladas com glicose (30mM) e/ou RLX (100ng/ml) por 48 horas. O grupo Prenhe mostrou-se mais protegido aos efeitos da OUU, com menor redução no clearance de creatinina e menos acúmulo de colágeno intersticial. No modelo in vitro, o estímulo com glicose estimulou a expressão do receptor de RLX (Rxfp1), de Colágeno e de TGFβ1 no grupo Virgem, mas não no grupo Prenhe. O tratamento com RLX preveniu as alterações observadas no grupo Virgem. Nossos resultados sugerem que elevados níveis de RLX endógena ou exógena, podem ter um papel protetor em processos fibrogênicos.Dados abertos - Sucupira - Teses e dissertações (2013 a 2016)Universidade Federal de São Paulo (UNIFESP)Boim, Mirian Aparecida [UNIFESP]http://lattes.cnpq.br/8916858915652849http://lattes.cnpq.br/7061959978075667Universidade Federal de São Paulo (UNIFESP)Figueiredo, Camila Médici de [UNIFESP]2018-07-30T11:45:00Z2018-07-30T11:45:00Z2016-04-29info:eu-repo/semantics/masterThesisinfo:eu-repo/semantics/publishedVersion30 f.application/pdfhttps://sucupira.capes.gov.br/sucupira/public/consultas/coleta/trabalhoConclusao/viewTrabalhoConclusao.jsf?popup=true&id_trabalho=3775720FIGUEIREDO, Camila Medici de. Avaliação do efeito antifibrótico da relaxina: estudo in vivo e in vitro. 2016. 30 f. Dissertação (Mestrado em Medicina Translacional) - Escola Paulista de Medicina, Universidade Federal de São Paulo (UNIFESP), São Paulo, 2016.Camila Médici de Figueiredo - PDF A.pdfhttps://repositorio.unifesp.br/handle/11600/47695ark:/48912/0013000004ttmporSão Pauloinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-01T17:59:06Zoai:repositorio.unifesp.br/:11600/47695Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-12-11T19:57:41.085653Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Avaliação do efeito antifibrótico da Relaxina: estudo in vivo e in vitro
Evaluation of antifibrotic effect of Relaxin: In vivo and in vitro study
title Avaliação do efeito antifibrótico da Relaxina: estudo in vivo e in vitro
spellingShingle Avaliação do efeito antifibrótico da Relaxina: estudo in vivo e in vitro
Figueiredo, Camila Médici de [UNIFESP]
Relaxin
Pregnancy
Renal fibrosis
Primary mesangial cell
Unilateral obstruction of the ureter
Relaxina
Gravidez
Fibrose renal
Célula mesangial primária
Obstrução unilateral do ureter
title_short Avaliação do efeito antifibrótico da Relaxina: estudo in vivo e in vitro
title_full Avaliação do efeito antifibrótico da Relaxina: estudo in vivo e in vitro
title_fullStr Avaliação do efeito antifibrótico da Relaxina: estudo in vivo e in vitro
title_full_unstemmed Avaliação do efeito antifibrótico da Relaxina: estudo in vivo e in vitro
title_sort Avaliação do efeito antifibrótico da Relaxina: estudo in vivo e in vitro
author Figueiredo, Camila Médici de [UNIFESP]
author_facet Figueiredo, Camila Médici de [UNIFESP]
author_role author
dc.contributor.none.fl_str_mv Boim, Mirian Aparecida [UNIFESP]
http://lattes.cnpq.br/8916858915652849
http://lattes.cnpq.br/7061959978075667
Universidade Federal de São Paulo (UNIFESP)
dc.contributor.author.fl_str_mv Figueiredo, Camila Médici de [UNIFESP]
dc.subject.por.fl_str_mv Relaxin
Pregnancy
Renal fibrosis
Primary mesangial cell
Unilateral obstruction of the ureter
Relaxina
Gravidez
Fibrose renal
Célula mesangial primária
Obstrução unilateral do ureter
topic Relaxin
Pregnancy
Renal fibrosis
Primary mesangial cell
Unilateral obstruction of the ureter
Relaxina
Gravidez
Fibrose renal
Célula mesangial primária
Obstrução unilateral do ureter
description Mesangial cells (MC) and its extracellular matrix are relevant to the maintenance of glomerular filtration rate by modulating the surface available for filtration. Under stimuli such as high glucose, MC proliferate and become hypersecretory of matrix proteins and pro-fibrotic factors such as TGFβ1, contributing to glomerular sclerosis. A number of the strategies have been tested in order to reduce the fibrogenic process dependent of TGFβ1 and in this context, the pregnancy related hormone Relaxin (RLX) has been explored due to its antifibrotic capacity. Usually related to pregnancy, RLX was capable to reduce TGFβ1-induced fibrosis, and increase the secretion of metalloproteinases, which degrade matrix proteins. Thus, the objective of this study was to evaluate if high levels of endogenous RLX found during pregnancy would be able to reduce the fibrogenic process induced by unilateral ureteral obstruction (UUO). Pregnant rats, which have high levels of RLX were used. Seven days pregnant rats were submitted to UUO for 7 or 15 days. In addition to the in vivo fibrosis model, we also evaluated an in vitro model using primary mesangial cells cultured from virgin and pregnant rats. MC were cultured from kidney of pregnant and virgin rats, and stimulated with high glucose concentration (30 mM) and/or RLX (100ng/ml) for 48 hours. The Pregnant group showed to be more protected against the effects of UUO with less reduction in creatinine clearance and less interstitial collagen accumulation. In the in vitro model, high glucose stimulated the expression of RLX receptor (Rxfp1), Collagen and TGFβ1 in the Virgin group but had no effect in MC from pregnant rats. Treatment with RLX prevented these changes in Virgin group. Our results suggest that elevated levels of endogenous or exogenous RLX may have a protective role in fibrogenic process.
publishDate 2016
dc.date.none.fl_str_mv 2016-04-29
2018-07-30T11:45:00Z
2018-07-30T11:45:00Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://sucupira.capes.gov.br/sucupira/public/consultas/coleta/trabalhoConclusao/viewTrabalhoConclusao.jsf?popup=true&id_trabalho=3775720
FIGUEIREDO, Camila Medici de. Avaliação do efeito antifibrótico da relaxina: estudo in vivo e in vitro. 2016. 30 f. Dissertação (Mestrado em Medicina Translacional) - Escola Paulista de Medicina, Universidade Federal de São Paulo (UNIFESP), São Paulo, 2016.
Camila Médici de Figueiredo - PDF A.pdf
https://repositorio.unifesp.br/handle/11600/47695
dc.identifier.dark.fl_str_mv ark:/48912/0013000004ttm
url https://sucupira.capes.gov.br/sucupira/public/consultas/coleta/trabalhoConclusao/viewTrabalhoConclusao.jsf?popup=true&id_trabalho=3775720
https://repositorio.unifesp.br/handle/11600/47695
identifier_str_mv FIGUEIREDO, Camila Medici de. Avaliação do efeito antifibrótico da relaxina: estudo in vivo e in vitro. 2016. 30 f. Dissertação (Mestrado em Medicina Translacional) - Escola Paulista de Medicina, Universidade Federal de São Paulo (UNIFESP), São Paulo, 2016.
Camila Médici de Figueiredo - PDF A.pdf
ark:/48912/0013000004ttm
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 30 f.
application/pdf
dc.coverage.none.fl_str_mv São Paulo
dc.publisher.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
publisher.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1818602403311648768